Graves' Disease Treatment in First Trimester Pregnancy

Treating Graves' disease during pregnancy requires careful consideration, especially in the first trimester, to balance maternal health and fetal safety.

Evaluating Treatment Options

• Radioiodine Therapy: This is generally contraindicated during pregnancy, particularly in the first trimester, as radioactive iodine can damage the developing fetal thyroid gland.
• Subtotal Thyroidectomy: While effective, surgery is typically reserved for cases where antithyroid medications are ineffective or not tolerated, or for specific complications. It is not usually the first-line treatment in pregnancy.
• Carbimazole: This antithyroid medication carries a risk of teratogenicity (causing birth defects) and is usually avoided during the first trimester.
• Propylthiouracil (PTU): PTU is often considered the preferred antithyroid drug during the first trimester. While it also carries potential risks, it is generally associated with a lower risk of certain birth defects compared to carbimazole or methimazole in early gestation. Close monitoring of both mother and fetus is essential.

Conclusion

For a 30-year-old woman in the first trimester of pregnancy with Graves' disease, Propylthiouracil is typically the treatment of choice among the available options.